Who can have parenteral antibiotics at home? A prospective observational study in children with moderate/severe cellulitis

Pediatric Infectious Disease Journal

Volumn 35, Issue 3, 2016, Pages 269-274

  Ibrahim, Laila F ^a,b,c   Hopper, Sandy M ^a,c   Babl, Franz E ^a,b,c   Bryant, Penelope A ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ambulatory; Antibiotics; Cellulitis; Hospital in the home; Intravenous

Indexed keywords

CEFTRIAXONE; FLUCLOXACILLIN; ANTIINFECTIVE AGENT;

ABSCESS; ADOLESCENT; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CELLULITIS; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; FEMALE; FEVER; GROUP A STREPTOCOCCAL INFECTION; HEALTH CARE QUALITY; HOME CARE; HOSPITAL ADMISSION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OBSERVATIONAL STUDY; ORBIT CELLULITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AMBULATORY CARE; AUSTRALIA; HEALTH CARE COST; HOME VISIT; HOSPITAL EMERGENCY SERVICE; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; AUSTRALIA; CELLULITIS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HOUSE CALLS; HUMANS; INFANT; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84959201317     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000992     Document Type: Article

References (27)

1. Nathwani D. The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom. Chemotherapy. 2001;47 (Suppl 1):17-23.
2. Barr DA, Semple L, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents. 2012;39:407-413.
3. Svahn BM, Remberger M, Heijbel M, et al. Case-control comparison of athome and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation. 2008;85:1000-1007.
4. Small F, Alderdice F, McCusker C, et al. A prospective cohort study comparing hospital admission for gastro-enteritis with home management. Child Care Health Dev. 2005;31:555-562.
5. Tiberg I, Katarina SC, Carlsson A, et al. Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care. Acta Paediatr. 2012;101:1069-1073.
6. Hansson H, Kjaergaard H, Johansen C, et al. Hospital-based home care for children with cancer: feasibility and psychosocial impact on children and their families. Pediatr Blood Cancer. 2013;60:865-872.
7. Balaguer A, Gonzalez de Dios J. Home versus hospital intravenous antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev. 2012;3:CD001917.
8. Corwin P, Toop L, McGeoch G, et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ. 2005;330:129.
9. Grayson ML, McDonald M, Gibson K, et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis. 2002;34:1440-1448.
10. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974;54:358-360.
11. Gouin S, Chevalier I, Gauthier M, et al. Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre. J Paediatr Child Health. 2008;44:214-218.
12. Stevens DL, Bisno AL, Chambers HF, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-1406.
13. Nelson SJ, Boies EG, Shackelford PG. Ceftriaxone in the treatment of infections caused by Staphylococcus aureus in children. Pediatr Infect Dis. 1985;4:27-31.
14. Frenkel LD. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children. Pediatrics. 1988;82(3 Pt 2):486-491.
15. Kulhanjian J, Dunphy MG, Hamstra S, et al. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children. Pediatr Infect Dis J. 1989;8:605-610.
16. Brugha RE, Abrahamson E. Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis. Pediatr Emerg Care. 2012;28:226-228.
17. Luca NJ, Lara-Corrales I, Pope E. Eczema herpeticum in children: clinical features and factors predictive of hospitalization. J Pediatr. 2012;161:671-675.
18. Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital. Pediatr Infect Dis J. 2013;32:346-349.
19. Farrell DJ, Castanheira M, Mendes RE, et al. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010). Clin Infect Dis. 2012;55 (Suppl 3):S206-S214.
20. Trenchs V, Hernandez-Bou S, Bianchi C, et al. Blood cultures are not useful in the evaluation of children with uncomplicated superficial skin and soft tissue infections. Pediatr Infect Dis J. 2015;34:924-927.
21. Vasconcellos AG, Leal RD, Silvany-Neto A, et al. Oxacillin or cefalotin treatment of hospitalized children with cellulitis. Jpn J Infect Dis. 2012;65:7-12.
22. Owens RC Jr, Donskey CJ, Gaynes RP, et al. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46 (Suppl 1):S19-S31.
23. Chapman AL, Dixon S, Andrews D, et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64:1316-1324.
24. Matthews PC, Conlon CP, Berendt AR, et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother. 2007;60:356-362.
25. Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC betalactamase: implications for antibiotic use. Antimicrob Agents Chemother. 2008;52:995-1000.
26. Spritzer R, vd Kamp HJ, Dzoljic G, et al. Five years of cefotaxime use in a neonatal intensive care unit. Pediatr Infect Dis J. 1990;9:92-96.
27. Gilbert EH, Lowenstein SR, Koziol-McLain J, et al. Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med. 1996;27:305-308.